A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice

The progressive accumulation of misfolded α-synuclein (α-syn) in the brain is widely considered to be causal for the debilitating clinical manifestations of synucleinopathies including, most notably, Parkinson’s disease (PD). Immunotherapies, both active and passive, against α-syn have been develope...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Sabine Schmidhuber, Sandra Scheiblhofer, Richard Weiss, Mihály Cserepes, József Tóvári, Gabriele Gadermaier, Erwan Bezard, Francesca De Giorgi, François Ichas, Dirk Strunk, Markus Mandler
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI AG 2022-08-01
سلاسل:	Vaccines
الموضوعات:	Parkinson’s disease vaccine vaccination strategy α-synuclein public health cost effectiveness
الوصول للمادة أونلاين:	https://www.mdpi.com/2076-393X/10/9/1432
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!